Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
Quarterly results move into focus for Houlihan Lokey stock
Houlihan Lokey (HLI) has drawn fresh attention after reporting quarterly revenue that declined from a year earlier and came in below analyst expectations, with management attributing the shortfall mainly to deal timing and software sector volatility.
At the same time, the company highlighted record fourth quarter revenue in its Corporate Finance and Financial and Valuation Advisory segments. It also pointed to recent wins, acquisitions, and international expansion as key drivers behind its constructive outlook.
See our latest analysis for Houlihan Lokey.
At a share price of $149.66, Houlihan Lokey has seen the share price fall 7.0% over the past month and 15.1% year to date, while the 5 year total shareholder return of 122.5% suggests long term holders have still seen strong gains. Recent quarterly softness and mixed deal activity appear to have cooled momentum rather than reset the longer term story.
If this mix of deal cyclicality and long term value creation has you thinking about what else might be setting up for the next few years, it could be worth scanning resilient businesses beyond investment banking using a curated list of founder led companies via the 20 top founder-led companies
With the stock down double digits over the past year, solid multi year returns, and active buybacks on the table, is Houlihan Lokey quietly offering value today, or is the market already pricing in its future growth?
Most Popular Narrative: 14.2% Undervalued
The most followed narrative pegs Houlihan Lokey’s fair value at $174.50, comfortably above the last close at $149.66. This frames a clear valuation gap to investigate further.
Increasing global corporate complexity and cross-border transactions are driving ongoing demand for independent advisory expertise, as evidenced by resilient revenues and continued international hiring and expansion initiatives. These factors are expected to support sustained top-line revenue growth.
Want to see what is underpinning that fair value gap? The narrative leans on steady revenue growth, firmer margins, and a future earnings profile that assumes Houlihan Lokey keeps winning mandates at scale.
Result: Fair Value of $174.50 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, there are still clear risks, including high compensation costs and dependence on U.S. deal activity, which could pressure margins and unsettle the current upside narrative.
Leave a comment